MARLANA COLEMAN: Open Payments
NPI 1285413120 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$922 in 31 payments from 12 companies in 2025. Trend: 2023 $1,047 · 2024 $261 · 2025 $922
Food & beverage: $922
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $187 |
| Stryker Corporation | 2 | $152 |
| AltaThera Pharmaceuticals LLC | 1 | $125 |
| PFIZER INC. | 4 | $94 |
| AtriCure, Inc. | 3 | $78 |
| Novo Nordisk Inc | 3 | $77 |
| E.R. Squibb & Sons, L.L.C. | 4 | $64 |
| Amgen Inc. | 3 | $48 |
| Alnylam Pharmaceuticals Inc. | 2 | $34 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $32 |
Products named: FLOWTRIEVER CATHETER, S, FARXIGA, Sotalol Hydrochloride, EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX, Wegovy, VYNDAQEL, CAMZYOS, REPATHA.
Industry payments across SC — which companies pay providers there.
